Global Polymerase Chain Reaction Market â€“ Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017â€“2023
Published Date:Mar 2019
Category:Healthcare & Pharmaceuticals
Polymerase chain reaction is a novel molecular diagnostic technology wherein DNA and RNA samples are amplified to form numerous copies of the same. This helps in better detection of diseases. This technology was developed by Kary Mullis in 1983. As more than two decades have passed since the evolution of PCR, the market is in a mature stage for standard PCR systems. In recent times, advances in technology have paved the way for the evolution of real-time PCR and digital PCR systems. Continuous technology advancements are making it more efficient and user-friendly, but the high cost of the instruments, servicing contracts, and reagents pose major challenges for the market, especially to the price-sensitive academics. Currently, the market players are involved in enhancing the capabilities of the PCR systems, and increasing its specificity and sensitivity.
The global polymerase chain reaction market is estimated to witness a CAGR of 9.91% during the forecast period 2017–2023. The global polymerase chain reaction market is analyzed based on four segments – products, application, end-users, and regions.
The market is witnessing an emerging trend of digital and droplet digital PCR technology, which is sensitive and accurate than the traditional method.
The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is the leading region for the polymerase chain reaction market followed by Europe. Asia Pacific and ROW are set to be the emerging regions.
The markets in India, Brazil, and China are also expected to grow at a rapid pace during the forecast period.
The market is segmented into instruments, reagents & consumables, and software & services. Reagents hold the largest share of the global polymerase chain reaction market, and is expected to exhibit the fastest growth during the forecast period.
The increasing use of PCR in genetic and molecular analysis, the advent of digital PCR technology are the key factors driving the market. The high cost of the instrument, dearth of skilled labors, competing technologies, such as NGS and microarray and stringent government regulations are factors restricting the market growth.
The application of PCR is predominant in clinical diagnostics, life sciences, and others. The life sciences segment holds the largest share in the market. But the market for clinical diagnostics is expected to grow rapidly due to the increasing adoption of PCR systems for the diagnosis of diseases. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which is defining the future of the global polymerase chain reaction market.
The end-users of PCR are hospitals, pharmaceutical & biotechnological companies, academics, and others (blood banks). Academics held a large market share in the PCR market in 2016. The demand for precise diagnosis of chronic diseases has increased in hospitals and diagnostic laboratories, which, in turn, will increase the growth rate of the global PCR market.
Thermo Fisher, Bio-Rad Laboratories, F. Hoffmann-La Roche, Abbott Laboratories, Merck KGaA, Becton Dickenson & company, Promega, Qiagen N.V., and Agilent Technologies are the key players in the market.
At present, the reagents and consumables are dominating the global polymerase chain reaction market. A lot of new players are focusing on developing real-time PCR instruments and reagents to gain future business opportunities. Major players in the market are involved in acquiring small players with advanced technology products to maintain leadership. For instance, Merck KGaA acquired Sigma-Aldrich Corporation, a multinational biotechnology company, making them one of the major players in the PCR reagents market. In January 2017, Bio-Rad entered into an agreement to acquire RainDance Technologies to strengthen the digital PCR and liquid biopsy segments of the company.
The report provides complete details about the usage and adoption rate of PCR in various verticals and regions. This enables the key stakeholders to know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward PCR adoption in the market. Moreover, the report provides details about the major challenges that are impacting the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business, increase their revenue, and analyze before investing or expanding the business in this market.
Title: Polymerase Chain Reaction (PCR) Market Trends 2017-2023
Desc: Thermo Fisher, Bio-Rad Laboratories, F. Hoffmann-La Roche, Abbott Laboratories, Merck KGaA, Becton Dickenson & company will lead the Polymerase Chain Reaction (PCR) Market. Click to know more on Polymerase Chain Reaction (PCR) Market trends.
Keyword: Polymerase Chain Reaction, DNA, RNA, Polymerase Chain Reaction Market, Polymerase Chain Reaction Market Trends
1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 PEST Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market
3.2 Segmented Addressable Market
3.3 Related Markets
3.3.1 Next Generation Sequencing
3.3.2 In-situ Hybridization
4 Market Outlook
4.1 Market Definition – Infoholic Research
4.2 Importance of Polymerase Chain Reaction
4.2.1 Medical Applications
4.2.2 Infectious Disease Diagnosis
4.2.3 Molecular Biology Research
4.3 Market Segmentation
4.4 Porter 5(Five) Forces
5 Market Characteristics
5.1 Polymerase Chain Reaction Technology Types
5.1.1 Real-Time PCR/qPCR
5.1.2 Nested PCR
5.1.3 Reverse Transcription PCR
5.1.4 Digital PCR
5.1.5 Assembly PCR
5.1.6 Multiplex PCR
5.1.7 Hot Start PCR
5.3 Polymerase Chain Reaction Advantages
5.4 Polymerase Chain Reaction Disadvantages
5.5 Market Dynamics
126.96.36.199 Rising demand for PCR in genetic and molecular testing
188.8.131.52 Expiry of key PCR patents
184.108.40.206 Advent of digital PCR technology
220.127.116.11 Growth of personalized medicines
18.104.22.168 Growing applications in the fields of life sciences research and clinical diagnostics
22.214.171.124 Lack of skilled labor
126.96.36.199 Competition from NGS and Microarray technology
188.8.131.52 Stringent government regulations
5.6 DRO – Impact Analysis
5.7 Key Stakeholders
6 Products: Market Size and Analysis
6.2.1 Standard PCR
6.2.2 Quantitative PCR/Real Time PCR
6.2.3 Digital PCR
6.3 Reagents and Consumables
6.4 Software and Services
7 Application: Market Size and Analysis
7.2 Clinical Diagnostics
7.3 Biomedical Research
8 End-users: Market Size and Analysis
8.2 Hospitals and Laboratories
8.3 Pharmaceutical Companies
9 Regions: Market Size and Analysis
9.4 Asia Pacific
9.5 Rest of the World
10 Competitive Landscape
11 Vendor Profiles
11.1 Bio-Rad Laboratories
11.1.2 Business Units
11.1.3 Geographic Presence
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategies
11.2 F. Hoffmann-La Roche Ltd.
11.2.2 Business Units
11.2.3 Geographic Presence
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 Thermo Fisher Scientific Inc.
11.3.2 Geographic Presence
11.3.3 Business Focus
11.3.4 SWOT Analysis
11.3.5 Business Strategies
11.4 Abbott Laboratories
11.4.2 Business Units
11.4.3 Geographic Presence
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategies
11.5 Agilent Technologies Inc.
11.5.2 Business Units
11.5.3 Geographic Presence
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
12 Companies to Watch For
12.1 Becton Dickinson and Company
12.2 Merck KGaA
12.3 Danaher Corporation
12.4 Promega Corp.
12.5 QIAGEN N.V.